MAKINDO MEDICINE · Biochemistry290
Clinical biochemistry: interpretation, test limitations and case mechanisms
Core principles: mechanisms are emphasised to explain clinical phenomena, physiological measurements and biochemical disease.
Patterns of common biochemical tests
| Test pattern | Mechanism | Important caution |
|---|---|---|
| High ALT/AST | Hepatocellular injury; AST also muscle | ALT/AST magnitude not direct measure of liver synthetic function |
| High ALP/GGT | Cholestasis or hepatobiliary enzyme induction | ALP also bone/placenta; GGT supports hepatic source |
| High bilirubin | Haemolysis, hepatocellular dysfunction or obstruction | Fractionate conjugated vs unconjugated |
| Raised troponin | Myocardial injury | Not synonymous with type 1 MI; need ischaemic evidence and serial change |
| High CK | Skeletal muscle injury | Rhabdomyolysis risk depends also on kidney injury/electrolytes |
| Low albumin | Inflammation, dilution, low synthesis or loss | Poor stand-alone nutritional marker |
| High lactate | Increased production or reduced clearance | Can occur without tissue hypoxia |
| Low sodium | Excess water relative to effective solute | Exclude artefact and hyperglycaemia-associated shifts |
| High potassium | Reduced excretion, redistribution or cell lysis | Rule out haemolysed sample, assess urgently if confirmed |
Interpreting calcium and bone biochemistry
- Total calcium is partly albumin bound; albumin-adjusted formulae are imperfect in critical illness and acid–base disturbance, so ionised calcium may be necessary.
- Primary hyperparathyroidism often shows high calcium, inappropriately normal/high PTH, low-to-normal phosphate; malignancy-associated hypercalcaemia often suppresses PTH.
- Renal failure can reduce calcitriol and increase phosphate, driving secondary hyperparathyroidism; chronic kidney disease mineral bone disorder is multifactorial.
- Raised ALP with normal GGT may arise from bone turnover; inspect age, pregnancy, recent fracture and disease context.
Diabetes-related biochemistry and endocrinology
- HbA1c represents haemoglobin glycation over erythrocyte lifespan; haemolysis, transfusion, haemoglobin variants, pregnancy or altered erythrocyte survival can make it misleading.
- DKA is driven by insulin deficiency with lipolysis and hepatic ketogenesis; serum beta-hydroxybutyrate is particularly informative and urine acetoacetate may lag recovery.
- Hyperosmolar hyperglycaemic state involves marked osmotic diuresis and dehydration with variable ketosis; evaluate effective osmolality and sodium correction.
- Hypoglycaemia work-up can require paired glucose, insulin, C-peptide, proinsulin and sulfonylurea screen when appropriate and supervised.
Biochemical diagnostic reasoning
- Start with pre-analytical effects: sample haemolysis, tourniquet duration, timing, recent meals, IV infusion contamination, circadian rhythm and medications.
- Recognise physiological adaptation versus pathology: e.g., pregnancy changes ALP, volume status changes urea, strenuous exercise raises CK/AST.
- Use trend and context rather than isolated numbers: sensitivity/specificity and reference interval depend on population and assay; a normal result never automatically excludes all disease.
- For patient care consult current UK laboratory reference ranges, local protocols and up-to-date clinical guidance; this atlas is educational.
End of chapter 290